UT Southwestern Medical Center awarded $12.6M from CPRIT

The grants provide funding for academic research as well as prevention screening programs
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
DALLAS—The University of Texas (UT) Southwestern Medical Center has announced the receipt of more than $12.6 million in research grants for cancer research and prevention from the Cancer Prevention and Research Institute of Texas (CPRIT), as well as $4 million for recruiting cancer scientists. This is part of the more than $89 million the CPRIT is awarding and announced on May 20. The institution awarded 28 grants through its academic research program, 11 through its prevention program and two through its product development research program.
Continue reading below...
An illustration showing red cancer cells surrounded by white immune cells interacting on a dark textured background.
ExplainersWhy does immunotherapy work better for some cancers than others?
A powerful tool in modern oncology, immunotherapy doesn’t work the same for everyone. Researchers are exploring why and developing ways to improve its effectiveness.
Read More
Four UT Southwestern researchers were awarded research grants at the Harold C. Simmons Comprehensive Cancer Center as part of the CPRIT's High-Impact/High-Risk Research Awards. In addition, two prevention grants were awarded to two UT Southwestern programs: one for breast cancer screening, which received $1.49 million, and one for colon cancer screening, which received $4.8 million, CPRIT's largest prevention grant to date.
“We are deeply grateful for this support from CPRIT and the people of Texas. These grants will fund important and innovative research projects and prevention programs, leading ultimately to improved treatments for cancer patients and more widespread prevention efforts for the population of Texas and beyond,” commented Dr. Daniel K. Podolsky, president of UT Southwestern and holder of the Philip O’Bryan Montgomery Jr., M.D., Distinguished Presidential Chair in Academic Administration and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science.
“These projects demonstrate the collaborative research efforts we value at the Simmons Cancer Center, and they encourage further discoveries that will help cancer patients,” Dr. James Wilson, associate dean of Oncology Programs at UT Southwestern and professor and director of the Simmons Cancer Center, said in a press release.
Continue reading below...
A digital illustration showing a T cell attacking a cancer cell, symbolizing the promise of immune-based therapies in tackling disease.
Ebooks Advancing cell therapies with smarter strategies
Researchers are finding creative ways to make cell therapies safer and more effective.
Read More
The grants will be applied to a variety of different initiatives. An award of $5.59 million will go to support the development of UT Southwestern's bioinformatics capability. UT Southwestern will receive a total of $800,000 in High-Impact/High-Risk Research Awards, which will support four initiatives, each of which will receive $200,000: Dynamin GTPase: A Novel Pro-Apoptotic Cancer Therapeutic Target; Acetate May Be a Key Substrate Driving Growth in Early Stage Breast Cancer in Patients; Identification of Novel Melanoma Metastasis Driver Genes through Transposon-Mediated Mutagenesis; and Identifying Inhibitors of Ascl1 to Block Growth of Malignant Neuroendocrine and Neural Tumors.
Other organizations that received some of the CPRIT's recent grants include the University of Texas MD Anderson Cancer Center, Texas A&M University (and its Health Science Center), Baylor College of Medicine, Rice University and the University of Texas at Arlington, among others. Since 2009, the CPRIT has awarded $1.33 billion in grants to date to Texas researchers, institutions and organizations.
Continue reading below...
Red tumor cells are shown against a teal backdrop showing attachment to tissue.
WhitepaperDecoding the tumor microenvironment with immune profiling
Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
Read More
All told, the CPRIT's recent academic research grants total approximately $60 million, with nearly $31 million of that going toward six Core Facilities Support Awards, which are meant to establish or further research facilities to support scientifically promising cancer research projects. The High-Impact/High-Risk grants are meant to contribute major new insights and ideas into the diagnosis, treatment and prevention of cancers, while the prevention awards provide funding for prevention services for underserved populations in Texas.
SOURCE: CPRIT press release

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue